...
首页> 外文期刊>The Professional Medical Journal >Evaluation of efficacy and adverse effects of paroxetine in the treatment of major depressive disorder patients.
【24h】

Evaluation of efficacy and adverse effects of paroxetine in the treatment of major depressive disorder patients.

机译:帕罗西汀在重大抑郁症患者治疗中的疗效和不良反应评价。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Major depressive disorder is a serious and disabling disease in world; it is a most common chronic and recurrent disorder with fourth cause of loss in disability in the worldwide. Objectives: To evaluate the efficacy and adverse effects of Paroxetine in major depressive disorder patients. Study Design: Open Labeled study. Setting: Department of Psychiatry, Chandka Medical College Hospital Larkano. Period: Three months (August to October 2019). Material & Methods: Total 40 patients of either sex were enrolled from OPD of Psychiatric department with age of 18 to 65 years. Follow-up visits were carried out fortnightly after making evaluation on symptoms at base line visit (day 0) continued till 90 days, and then results were compiled. The SPSS-16 version was used for the analysis of data. Results: Paroxetine is highly significant (p=0.001) to decrease the symptoms of depression during treatment of 90 days. Conclusion: In this study, Paroxetine is more effective drug to decrease the symptoms like, weight loss, sexual disturbance, insomnia and with less adverse effects in patients of major depressive disorder.
机译:主要抑郁症是世界上严重和致残的疾病;它是一种最常见的慢性和复发性疾病,并在全球残疾失败原因。目的:评估帕罗西汀在重大抑郁症患者中的疗效和不良影响。研究设计:开放标记研究。环境:Chandka医学院医院莱卡诺精神病学系。期间:三个月(八月至2019年10月)。材料和方法:18至65岁的精神病学家ope的40例两性患者。在评估基线访问(第0天)的症状评估后,每两周一次进行后续访问,直到90天,并编制结果。 SPSS-16版本用于分析数据。结果:帕罗西汀非常重要(p = 0.001),以减少治疗90天的抑郁症状。结论:在这项研究中,帕罗西汀是更有效的药物,可降低重症抑郁症患者的症状,减肥,性扰动,失眠,失眠,对患者的不利影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号